Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243347 · ClinicalTrials.gov registry record · Phase 1
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00243347 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 19 participants.
The verdict
NCT00243347, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study is to examine the effects on tumors of AZD2171, in the treatment of NSCLC or HNC. The safety and tolerability of AZD2171 will also be studied.
Interventions
- DRUG AZD2171
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243347
The ClinicalTrials.gov registry entry for NCT00243347 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AZD2171 is the first listed.
NCT00243347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243347 about?
NCT00243347 is a clinical study titled "The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer". This study is to examine the effects on tumors of AZD2171, in the treatment of NSCLC or HNC. The safety and tolerability of AZD2171 will also be studied.
What is the current status of trial NCT00243347?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2005-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00243347?
The interventions under investigation include: AZD2171 (DRUG).
Who is sponsoring clinical trial NCT00243347?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.